Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tran, P. O. T.
Right arrow Articles by Robertson, R. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tran, P. O. T.
Right arrow Articles by Robertson, R. P.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 51:1772-1778, 2002
© 2002 by the American Diabetes Association, Inc.

Inhibition of Interleukin-1ß-Induced COX-2 and EP3 Gene Expression by Sodium Salicylate Enhances Pancreatic Islet ß-Cell Function

Phuong Oanh T. Tran, Catherine E. Gleason, and R. Paul Robertson

From the Pacific Northwest Research Institute and Departments of Medicine and Pharmacology, University of Washington, Seattle, Washington

Previous work has suggested that functional interrelationships may exist between inhibition of insulin secretion by interleukin (IL)-1ß and the endogenous synthesis of prostaglandin E2 (PGE2) in the pancreatic islet. These studies were performed to ascertain the relative abundance of E prostaglandin (EP) receptor mRNAs in tissues that are major targets, or major degradative sites, of insulin; to identify which EP receptor type mediates PGE2 inhibition of insulin secretion in pancreatic islets; and to examine possible sites of action through which sodium salicylate might affect IL-1ß/PGE2 interactions. Real-time fluorescence-based RT-PCR indicated that EP3 is the most abundant EP receptor type in islets, liver, kidney, and epididymal fat. EP3 mRNA is the least, whereas EP2 mRNA is the most, abundant type in skeletal muscle. Misoprostol, an EP3 agonist, inhibited glucose-induced insulin secretion from islets, an event that was prevented by preincubation with pertussis toxin, by decreasing cAMP. Electromobility shift assays demonstrated that sodium salicylate inhibits IL-1ß-induced nuclear factor-{kappa}B (NF-{kappa}B) activation. Sodium salicylate also prevented IL-1ß from inducing EP3 and cyclooxygenase (COX)-2 gene expression in islets and thereby prevented IL-1ß from inhibiting glucose-induced insulin secretion. These findings indicate that the sites of action through which sodium salicylate inhibits these negative effects of IL-1ß on ß-cell function include activation of NF-{kappa}B as well as generation of PGE2 by COX-2.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 DiabetesHome page
S. J. Persaud, D. Muller, V. D. Belin, I. Kitsou-Mylona, H. Asare-Anane, A. Papadimitriou, C. J. Burns, G. C. Huang, S. A. Amiel, and P. M. Jones
The Role of Arachidonic Acid and Its Metabolites in Insulin Secretion From Human Islets of Langerhans
Diabetes, January 1, 2007; 56(1): 197 - 203.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. K. Hagman, L. B. Hays, S. D. Parazzoli, and V. Poitout{paragraph}
Palmitate Inhibits Insulin Gene Expression by Altering PDX-1 Nuclear Localization and Reducing MafA Expression in Isolated Rat Islets of Langerhans
J. Biol. Chem., September 16, 2005; 280(37): 32413 - 32418.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
N. R. Barshes, S. Wyllie, and J. A. Goss
Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts
J. Leukoc. Biol., May 1, 2005; 77(5): 587 - 597.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. R. Heitmeier, C. B. Kelly, N. J. Ensor, K. A. Gibson, K. G. Mullis, J. A. Corbett, and T. J. Maziasz
Role of Cyclooxygenase-2 in Cytokine-induced {beta}-Cell Dysfunction and Damage by Isolated Rat and Human Islets
J. Biol. Chem., December 17, 2004; 279(51): 53145 - 53151.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. Zeender, K. Maedler, D. Bosco, T. Berney, M. Y. Donath, and P. A. Halban
Pioglitazone and Sodium Salicylate Protect Human {beta}-Cells against Apoptosis and Impaired Function Induced by Glucose and Interleukin-1{beta}
J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 5059 - 5066.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
T. Tabatabaie, A. Vasquez-Weldon, D. R. Moore, and Y. Kotake
Free Radicals and the Pathogenesis of Type 1 Diabetes: {beta}-Cell Cytokine-Mediated Free Radical Generation Via Cyclooxygenase-2
Diabetes, August 1, 2003; 52(8): 1994 - 1999.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
M. E. Bizeau, P. S. MacLean, G. C. Johnson, and Y. Wei
Skeletal Muscle Sterol Regulatory Element Binding Protein-1c Decreases with Food Deprivation and Increases with Feeding in Rats
J. Nutr., June 1, 2003; 133(6): 1787 - 1792.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2002 by the American Diabetes Association.